Your session is about to expire
← Back to Search
One-Stage vs Two-Stage Orchidopexy for Undescended Testicles (GSLO Trial)
GSLO Trial Summary
This trial found that one stage GSLO does not lead to an increased risk of testicular atrophy when compared to the two stage GSLO surgery.
GSLO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGSLO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GSLO Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To what extent is this investigation being participatory?
"Affirmative, clinicaltrials.gov lists this trial as actively searching for participants with an original post date of April 11th 2017 and a most recent update on April 4th 2022. The study is aiming to find 80 volunteers at one site in total."
Are there still opportunities to participate in this clinical research?
"Per records on clinicaltrials.gov, recruitment for this study is still underway. It was initially posted in April 2017 and last altered a few days ago, at the start of April 2022."
Is this clinical trial open to persons aged 35 and above?
"This research study necessitates that those recruited are between 1 year and 5 years of age. There are an additional five investigations targeting patients under the legal age of consent, as well as one for people above 65."
What qualifications must a person possess to be accepted into this medical experiment?
"Candidates who have cryptorchidism and are within the age range of 1 to 5 years can apply for recruitment into this clinical trial, which is set to accept up to 80 participants."
Share this study with friends
Copy Link
Messenger